163 related articles for article (PubMed ID: 34419749)
1. Generation of a COL4A5 heterozygous mutation human embryonic stem cell line (WAe009-A-58) using an episomal vector-based CRISPR/Cas9 system.
Tian L; Wu F; Bai R; Ma S; Zheng H; Liu WJ; Wang Y
Stem Cell Res; 2021 Aug; 55():102481. PubMed ID: 34419749
[TBL] [Abstract][Full Text] [Related]
2. Generation of an induced pluripotent stem cell line (SHCDNRi001-A) from a patient with X-linked Alport syndrome carrying a heterozygous p.G409S (c. 1225 G > A) mutation in the COL4A5 gene.
Sun L; Zhang J; Kuang XY; Kang YL; Wu Y; Huang WY
Stem Cell Res; 2020 May; 45():101833. PubMed ID: 32416580
[TBL] [Abstract][Full Text] [Related]
3. Effect of heterozygous pathogenic COL4A3 or COL4A4 variants on patients with X-linked Alport syndrome.
Zhang Y; Ding J; Zhang H; Yao Y; Xiao H; Wang S; Wang F
Mol Genet Genomic Med; 2019 May; 7(5):e647. PubMed ID: 30883042
[TBL] [Abstract][Full Text] [Related]
4. Generating dHAND homozygous knockout human embryonic stem cell line (WAe009-A-59) by episomal vector-based CRISPR/Cas9 system.
Wang W; Bai R; Song X
Stem Cell Res; 2021 Aug; 55():102471. PubMed ID: 34332328
[TBL] [Abstract][Full Text] [Related]
5. Generation of a Junctophilin-2 homozygous knockout human embryonic stem cell line (WAe009-A-36) by an episomal vector-based CRISPR/Cas9 system.
Wu F; Li X; Bai R; Li Y; Gao J; Lan F
Stem Cell Res; 2020 Oct; 48():101930. PubMed ID: 32777767
[TBL] [Abstract][Full Text] [Related]
6. A case with somatic and germline mosaicism in COL4A5 detected by multiplex ligation-dependent probe amplification in X-linked Alport syndrome.
Aoto Y; Kise T; Nakanishi K; Nagano C; Horinouchi T; Yamamura T; Ishiko S; Sakakibara N; Shima Y; Morisada N; Iijima K; Nozu K
CEN Case Rep; 2020 Nov; 9(4):431-436. PubMed ID: 32621070
[TBL] [Abstract][Full Text] [Related]
7. Generation of an iPSC line (GWCMCi002-A) from an X-linked Alport syndrome patient with a hemizygous splicing mutation (NM_000495.4, c. 1517-1 G > T) in the COL4A5 gene.
Gao X; Li G; Deng H; Feng W; Li Y; Liu M; Li Y
Stem Cell Res; 2021 May; 53():102388. PubMed ID: 34088015
[TBL] [Abstract][Full Text] [Related]
8. Generation of integration-free induced pluripotent stem cell lines derived from two patients with X-linked Alport syndrome (XLAS).
Kuebler B; Aran B; Miquel-Serra L; Muñoz Y; Ars E; Bullich G; Furlano M; Torra R; Marti M; Veiga A; Raya A
Stem Cell Res; 2017 Dec; 25():291-295. PubMed ID: 29150092
[TBL] [Abstract][Full Text] [Related]
9. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
10. Generation of a FLNA knockout hESC line (WAe009-A-P) to model cardiac valvular dysplasia using CRISPR/Cas9.
Lu F; Gao Y; Li E
Stem Cell Res; 2023 Sep; 71():103162. PubMed ID: 37429070
[TBL] [Abstract][Full Text] [Related]
11. Establishment of a human TLR4 compound heterozygous knockout hESC line (WAe009-A-N) to model toll-like receptor 4 deficiency by CRISPR/Cas9 system.
Ruan Y; Tian X; Li X; Zhang Y
Stem Cell Res; 2023 Dec; 73():103225. PubMed ID: 37931537
[TBL] [Abstract][Full Text] [Related]
12. A CRISPR/Cas9 strategy for the generation of a FLNC knockout hESC line (WAe009-A-70) to model dilated cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy.
Qin Z; Sun L; Sun X; Su H; Gao X
Stem Cell Res; 2021 Oct; 56():102562. PubMed ID: 34634758
[TBL] [Abstract][Full Text] [Related]
13. Generation of a TLR7 heterozygous knockout line (WAe009-A-18) from human embryonic stem cells using CRISPR/Cas9.
Seo HH; Han HW; Kim JH
Stem Cell Res; 2020 May; 45():101735. PubMed ID: 32268246
[TBL] [Abstract][Full Text] [Related]
14. X-linked Alport syndrome associated with a synonymous p.Gly292Gly mutation alters the splicing donor site of the type IV collagen alpha chain 5 gene.
Fu XJ; Nozu K; Eguchi A; Nozu Y; Morisada N; Shono A; Taniguchi-Ikeda M; Shima Y; Nakanishi K; Vorechovsky I; Iijima K
Clin Exp Nephrol; 2016 Oct; 20(5):699-702. PubMed ID: 26581810
[TBL] [Abstract][Full Text] [Related]
15. Generation of two induced pluripotent stem cell lines from patients with X-linked Alport syndrome.
Ma Y; Wang Z; Gao M; Liu X; Sun W; Gong Y; Sun G; Liu G
Stem Cell Res; 2021 May; 53():102343. PubMed ID: 33878711
[TBL] [Abstract][Full Text] [Related]
16. The Alport syndrome COL4A5 variant database.
Crockett DK; Pont-Kingdon G; Gedge F; Sumner K; Seamons R; Lyon E
Hum Mutat; 2010 Aug; 31(8):E1652-7. PubMed ID: 20574986
[TBL] [Abstract][Full Text] [Related]
17. Genetic testing for X-linked Alport syndrome by direct sequencing of COL4A5 cDNA from hair root RNA samples.
Tazón-Vega B; Ars E; Burset M; Santín S; Ruíz P; Fernández-Llama P; Ballarín J; Torra R
Am J Kidney Dis; 2007 Aug; 50(2):257.e1-14. PubMed ID: 17660027
[TBL] [Abstract][Full Text] [Related]
18. Female X-linked Alport syndrome with somatic mosaicism.
Yokota K; Nozu K; Minamikawa S; Yamamura T; Nakanishi K; Kaneda H; Hamada R; Nozu Y; Shono A; Ninchoji T; Morisada N; Ishimori S; Fujimura J; Horinouchi T; Kaito H; Nakanishi K; Morioka I; Taniguchi-Ikeda M; Iijima K
Clin Exp Nephrol; 2017 Oct; 21(5):877-883. PubMed ID: 27796712
[TBL] [Abstract][Full Text] [Related]
19. Collagen type IV-related nephropathies in Portugal: pathogenic COL4A5 mutations and clinical characterization of 22 families.
Nabais Sá MJ; Sampaio S; Oliveira A; Alves S; Moura CP; Silva SE; Castro R; Araújo JA; Rodrigues M; Neves F; Seabra J; Soares C; Gaspar MA; Tavares I; Freitas L; Sousa TC; Henriques AC; Costa FT; Morgado E; Sousa FT; Sousa JP; da Costa AG; Filipe R; Garrido J; Montalban J; Ponce P; Alves R; Faria B; Carvalho MF; Pestana M; Carvalho F; Oliveira JP
Clin Genet; 2015 Nov; 88(5):462-7. PubMed ID: 25307721
[TBL] [Abstract][Full Text] [Related]
20. Functional assessment of a novel COL4A5 splice region variant and immunostaining of plucked hair follicles as an alternative method of diagnosis in X-linked Alport syndrome.
Malone AF; Funk SD; Alhamad T; Miner JH
Pediatr Nephrol; 2017 Jun; 32(6):997-1003. PubMed ID: 28013382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
